Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6167 | 1456 | 32.9 | 66% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
87 | 25794 | HERPES SIMPLEX VIRUS//VARICELLA ZOSTER VIRUS//HERPES ZOSTER |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ACYCLOVIR RESISTANCE | Author keyword | 16 | 61% | 1% | 17 |
2 | ASP2151 | Author keyword | 11 | 100% | 0% | 6 |
3 | BAY 57 1293 | Author keyword | 11 | 100% | 0% | 6 |
4 | ACYCLOVIR RESISTANT | Author keyword | 8 | 100% | 0% | 5 |
5 | HELICASE PRIMASE INHIBITOR | Author keyword | 6 | 80% | 0% | 4 |
6 | FAMCICLOVIR | Author keyword | 6 | 20% | 2% | 28 |
7 | GERMAN REFERENCE HSV VZV | Address | 6 | 53% | 1% | 8 |
8 | PENCICLOVIR | Author keyword | 6 | 26% | 1% | 20 |
9 | ACV RESISTANCE | Author keyword | 6 | 100% | 0% | 4 |
10 | AMENAMEVIR | Author keyword | 6 | 100% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ACYCLOVIR RESISTANCE | 16 | 61% | 1% | 17 | Search ACYCLOVIR+RESISTANCE | Search ACYCLOVIR+RESISTANCE |
2 | ASP2151 | 11 | 100% | 0% | 6 | Search ASP2151 | Search ASP2151 |
3 | BAY 57 1293 | 11 | 100% | 0% | 6 | Search BAY+57+1293 | Search BAY+57+1293 |
4 | ACYCLOVIR RESISTANT | 8 | 100% | 0% | 5 | Search ACYCLOVIR+RESISTANT | Search ACYCLOVIR+RESISTANT |
5 | HELICASE PRIMASE INHIBITOR | 6 | 80% | 0% | 4 | Search HELICASE+PRIMASE+INHIBITOR | Search HELICASE+PRIMASE+INHIBITOR |
6 | FAMCICLOVIR | 6 | 20% | 2% | 28 | Search FAMCICLOVIR | Search FAMCICLOVIR |
7 | PENCICLOVIR | 6 | 26% | 1% | 20 | Search PENCICLOVIR | Search PENCICLOVIR |
8 | ACV RESISTANCE | 6 | 100% | 0% | 4 | Search ACV+RESISTANCE | Search ACV+RESISTANCE |
9 | AMENAMEVIR | 6 | 100% | 0% | 4 | Search AMENAMEVIR | Search AMENAMEVIR |
10 | ACICLOVIR RESISTANCE | 4 | 75% | 0% | 3 | Search ACICLOVIR+RESISTANCE | Search ACICLOVIR+RESISTANCE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ACYCLOVIR RESISTANT | 54 | 57% | 4% | 64 |
2 | ANTIHERPESVIRUS ACTIVITY | 42 | 73% | 2% | 32 |
3 | BRL 39123 | 39 | 67% | 2% | 35 |
4 | THYMIDINE KINASE DEFICIENT | 30 | 100% | 1% | 12 |
5 | ALTERED SUBSTRATE SPECIFICITY | 27 | 74% | 1% | 20 |
6 | FOSCARNET THERAPY | 26 | 53% | 2% | 34 |
7 | PENCICLOVIR | 24 | 36% | 4% | 54 |
8 | BAY 57 1293 | 21 | 90% | 1% | 9 |
9 | ANTIVIRAL DRUGS | 20 | 22% | 6% | 82 |
10 | MUCOCUTANEOUS INFECTION | 17 | 59% | 1% | 19 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Resistance of Herpes Simplex Viruses to Nucleoside Analogues: Mechanisms, Prevalence, and Management | 2011 | 92 | 229 | 67% |
Antiviral drug resistance in herpesviruses other than cytomegalovirus | 2014 | 10 | 178 | 75% |
Herpes simplex virus resistance to antiviral drugs | 2003 | 166 | 48 | 90% |
Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy | 2003 | 163 | 88 | 69% |
Herpes simplex virus drug-resistance: new mutations and insights | 2013 | 10 | 55 | 71% |
Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms | 2002 | 157 | 180 | 39% |
Antiviral drug resistance and helicase-primase inhibitors of herpes simplex virus | 2011 | 17 | 39 | 77% |
HERPES-SIMPLEX VIRUS-RESISTANCE TO ACYCLOVIR - CLINICAL RELEVANCE | 1995 | 64 | 87 | 70% |
The clinical pharmacokinetics of famciclovir | 1996 | 36 | 11 | 82% |
Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer | 2009 | 10 | 44 | 57% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GERMAN REFERENCE HSV VZV | 6 | 53% | 0.5% | 8 |
2 | ANTIMICROBIAL HOST DEF EXCELLENCE DRUG DISC | 2 | 44% | 0.3% | 4 |
3 | ANTIVIRAL BIOL | 1 | 50% | 0.1% | 2 |
4 | DETIV | 1 | 50% | 0.1% | 2 |
5 | UK VIROL MED | 1 | 100% | 0.1% | 2 |
6 | ER1 | 1 | 40% | 0.1% | 2 |
7 | IVANOVSKII VIROL | 1 | 33% | 0.1% | 2 |
8 | AICURIS | 1 | 50% | 0.1% | 1 |
9 | ANTIVIRAL TUMOR TRADIT CHINESE MED | 1 | 50% | 0.1% | 1 |
10 | BIOANALYT CLIN | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000272443 | ACYCLOVIR//9 CARBOXYMETHOXYMETHYLGUANINE//VALACYCLOVIR |
2 | 0.0000244872 | BV ARAU//5 ETHYL 2 DEOXYURIDINE//BCNA |
3 | 0.0000162076 | GENITAL HERPES//NEONATAL HERPES//HSV 2 |
4 | 0.0000153047 | AREA TER IA CELULAR//SECC MODELIZAC MOL//SECC SINTESIS |
5 | 0.0000141732 | ICP8//UL9//ALKALINE NUCLEASE |
6 | 0.0000116162 | ACYCLIC NUCLEOSIDE PHOSPHONATES//ACYCLIC NUCLEOSIDE PHOSPHONATE//PMEA |
7 | 0.0000112237 | NEUROBIOL VACCINE DEV//HERPES SIMPLEX KERATITIS//HERPETIC STROMAL KERATITIS |
8 | 0.0000087892 | PRUNELLA VULGARIS L//PRUNELLA VULGARIS VAR LILACINA//PRUNELLA VULGARIS |
9 | 0.0000076329 | CMV DNA LOAD//HERPES HEPATITIS//HERPES SIMPLEX VIRUS PNEUMONIA |
10 | 0.0000070303 | HERPES ZOSTER//POST HERPETIC NEURALGIA//SHINGLES |